The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

Quantum computing has long been announced as “just around the corner,” but several companies are now determined to make this ...

We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look ...

Merck, the Pharma giant with operations in Lansdale, announced on Tuesday that it will build a $1 billion “biologics center ...

A low-grade fever ranges from 99.5 F to 100.2 F. This article covers symptoms, causes, and home treatment for a mild fever.

As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's ...

CG Oncology Inc.’s latest research effort to treat bladder cancer is impressing investors.The Irvine-based biopharmaceutical ...

Immutep believes its LAG-3 candidate eftilagimod alpha may have a path to approval in first-line head and neck cancer after reporting what one analyst deems “impressive” overall survival data. | ...

Immutep Limited’s IMMP share price has surged by 28.47%, which has investors questioning if this is right time to sell.

During a live event, Krish Patel, MD, surveyed participants on using bispecific T-cell engagers vs loncastuximab in a patient with relapsed diffuse large B-cell lymphoma who had prior CAR T-cell ...

Millipore Sigma, one of the largest suppliers of medical research products, will start adding a temporary tariff surcharge to ...